Green Cross Health Ltd
NZX:GXH
Relative Value
The Relative Value of one
GXH
stock under the Base Case scenario is
1.8
NZD.
Compared to the current market price of 1.22 NZD,
Green Cross Health Ltd
is
Undervalued by 32%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
GXH Competitors Multiples
Green Cross Health Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NZ |
|
Green Cross Health Ltd
NZX:GXH
|
176.1m NZD | 0.3 | 10.1 | 7.2 | 7.2 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
70.5B ZAR | 1.5 | 23.5 | 11.5 | 16.2 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
29.4B ZAR | 0.8 | 25 | 10.1 | 15.4 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | 0.1 | -1.6 | 3 | 5.1 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
42.1B BRL | 1 | 32.4 | 10.3 | 18.2 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
1T JPY | 0.9 | 28.8 | 12.4 | 18.4 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
975.1B JPY | 0.9 | 17.4 | 8.2 | 10.4 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 1.7 | 20.7 | 10.4 | 19.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
28.8B CNY | 1.2 | 17.6 | 13.7 | 13.7 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 0.5 | 34.3 | 9.1 | 15.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
638.3B JPY | 0.6 | 15.1 | 9.2 | 13 |